Amar Remedies

Amar Remedies' acquisition can boost revenues by 80%, says PKH Ventures

PKH Ventures is currently in the process of acquiring Amar Remedies, an NSE- and BSE-listed public company, through the IBC process.

NSE to suspend trading in 10 securities from Dec 10

Leading bourse NSE will suspend trading in shares of 1O companies including Asian Electronics and Edserv Softsystems for not complying with various provisions of the listing pact.

Blue Square Corporate sells entire stake in Amar Remedies

Amar Remedies' stock on Friday closed at Rs 7.54, up 0.53 percent from previous close. Market capitalisation of the company currently stands at Rs 19.73 crore.

Ratnakar Bank sells 14.99 lakh shares of Amar Remedies

On October 09, 2013 The Ratnakar Bank Ltd. sold 14,99,500 shares of Amar Remedies at Rs 8.33 on the NSE. In the previous trading session, the share closed at Rs 8.15, down Rs 0.42, or 4.90 percent.

Amar Remedies standalone Jun '13 sales at Rs 45.15 crore

Amar Remedies has reported a standalone sales turnover of Rs 45.15 crore and a net loss of Rs 28.86 crore for the quarter ended Jun '13

Stocks in news: Idea Cellular, RComm, Hero, IOC, Glenmark

Stocks in news: Jet Airways, Zuari Agro, Sesa Goa, Prestige

Amar Remedies standalone Mar '13 sales at Rs 130.98 crore

Amar Remedies has reported a standalone sales turnover of Rs 130.98 crore and a net loss of Rs 16.14 crore for the quarter ended Mar '13

Amar Remedies standalone Dec '12 sales at Rs 163.05 crore

Amar Remedies has reported a sales standalone turnover of Rs 163.05 crore and a net profit of Rs 1.33 crore for the quarter ended Dec '12

Nifty can slip to 5650; get expert's stock advice here

Moneycontrol.com got Hitesh Seth, head technical, Prabhudas Lilladher to answer the stock queries you sent us on our Facebook page as part of KYI (Know Your Investment). Check out his comments.

Bank of India sells 2.75 lakh shares of Amar Remedies

On September 26, 2012 Bank of India sold 275,277 shares of Amar Remedies at Rs 29.81 on the NSE. Yesterday the shares ended at Rs 31.85, up Rs 1.50, or 4.94%. It touched a 52-week low of Rs 28.85. It has touched an intraday high of Rs 31.85 and an intraday low of Rs 28.85.

L&T Finance sells 189000 shares of Amar Remedies

On September 17, 2012 L&T Finance Limited sold 189,000 shares of Amar Remedies at Rs 36.25 on the NSE. Yesterday it touched a 52-week low of Rs 34.30. The share closed at Rs 35.30, down Rs 0.35, or 0.98%.

L&T Finance sells 1.43 lakh shares of Amar Remedies

On September 14, 2012 L&T Finance Limited sold 143,000 shares of Amar Remedies at Rs 36.21 on the NSE. In the last trading session share touched a 52-week low of Rs 35.60. It ended at Rs 35.65, down Rs 1.80, or 4.81%.

SE Investments sells 3.50 lakh shares of Amar Remedies

On August 01, 2012 SE Investments Limited sold 350,000 shares of Amar Remedies at Rs 65.3 on the NSE.

Mentor Capital buys shares worth Rs 4.3 cr of Amar Remedies

Shares of Amar Remedies, a manufacturer and exporter of premier personal hygiene products, gained as much as 7% intraday on Wednesday. Mentor Capital had bought 6 lakh shares of the company worth Rs 4.3 crore yesterday.

Amar Remedies locked in lower circuit; slips 36% in 2 days

Amar Remedies has locked at 20% lower circuit. It touched an intraday high of Rs 105.00 and an intraday low of Rs 88.45. At 10:38 hrs the share was quoting at Rs 88.45, down Rs 22.05.

Amar Remedies Mar '12 sales at Rs 169.29 crore

Amar Remedies has reported a sales turnover of Rs 169.29 crore and a net profit of Rs 12.97 crore for the quarter ended Mar '12

Bull's Eye: Buy Balaji Tele, TCS, M&M, HUL, Sun Pharma

CNBC-TV18 brings you a brand new week of Bull's Eye. It's the popular game show where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.